13-G for Saigene Corporation

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CaGzUu23HxoEDSANmn+Z4syf3f2LeuQT2XTFwd0u8vhcM4yT6zOFC6JrCvscXvNX lFDKWZGC15UjsuBoAWwl3g== 0001017062-03-000258.txt : 20030214 0001017062-03-000258.hdr.sgml : 20030214 20030214134500 ACCESSION NUMBER: 0001017062-03-000258 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOMETRICS INC CENTRAL INDEX KEY: 0001020475 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 931211114 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-78351 FILM NUMBER: 03565739 BUSINESS ADDRESS: STREET 1: 23120 ALICA PARKWAY STREET 2: SUITE 200 CITY: MISSION VIEJO STATE: CA ZIP: 92692 BUSINESS PHONE: 9494559724 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SAIGENE CORP CENTRAL INDEX KEY: 0001030423 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 911736814 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1725 220TH ST, SE STREET 2: # 104 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 2064855377 MAIL ADDRESS: STREET 1: 1725 220TH STREET SE STREET 2: #104 CITY: BOTHELL STATE: WA ZIP: 98021 SC 13G 1 dsc13g.htm 13-G FOR SAIGENE CORPORATION 13-G for Saigene Corporation

Schedule 13G

Page 1 of 5

OMB APPROVAL

OMB Number:		3235-0145

Expires:		December 31, 2005

Estimated average burden
hours per response . . . 11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. )*

Pacific Biometrics, Inc.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

69403Q100

(CUSIP Number)

December 31, 2002

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Schedule 13G

Page 2 of 5

CUSIP No. 69403Q100


1.		Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Saigene Corporation (91-1736814)

2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) ¨

3.		SEC Use Only

4.		Citizenship or Place of Organization Delaware

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5. Sole Voting Power

19,163,213

6. Shared Voting Power

7. Sole Dispositive Power

19,163,213

8. Shared Dispositive Power

9.		Aggregate Amount Beneficially Owned by Each Reporting Person 19,163,213

10.		Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

11.		Percent of Class Represented by Amount in Row (9) 75.28%

12.		Type of Reporting Person (See Instructions) CO

Schedule 13G

Page 3 of 5

Item 1.

	(a)		Pacific Biometrics, Inc. (“PBI”), a Delaware corporation.

	(b)		220 West Harrison Street, Seattle, Washington 98119.

Item 2.

	(a)		Saigene Corporation (“Saigene”).

	(b)		220 West Harrison Street, Seattle, Washington 98119.

	(c)		Delaware corporation.

	(d)		See cover page.

	(e)		See cover page.

Item 3.	If This Statement is Filed Pursuant to Rule 13d-1(b) or 13d-2(b) or (c), Check Whether the Person Filing is a:

	(a)	¨	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

	(b)	¨	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

	(c)	¨	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

	(d)	¨	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

	(e)	¨	An investment adviser in accordance with ss. 240.13d-1(b)(1)(ii)(E);

	(f)	¨	An employee benefit plan or endowment fund in accordance with ss. 240.13d-1(b)(1)(ii)(F);

	(g)	¨	A parent holding company or control person in accordance with ss. 240.13d- 1(b)(1)(ii)(G);

	(h)	¨	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

	(i)	¨	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

	(j)	¨	Group, in accordance with ss. 240.13d-I(b)(1)(ii)(J).

Schedule 13G

Page 4 of 5


Item 4.	Ownership.

	(a)	See Row 9 on Page 2.

	(b)	See Row 11 on Page 2.

	(c)	Saigene retains sole voting and dispositive power for all shares.

Item 5.	Ownership of Five Percent or Less of a Class.
	IF THIS STATEMENT IS BEING FILED TO REPORT THE FACT THAT AS OF THE DATE HEREOF THE REPORTING PERSON HAS CEASED TO BE THE BENEFICIAL OWNER OF MORE THAN FIVE PERCENT OF THE CLASS OF SECURITIES, CHECK THE FOLLOWING ¨ .

Item 6.	Ownership of More than Five Percent on Behalf of Another Person.
	Not Applicable.

Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

	Not Applicable.

Item 8.	Identification and Classification of Members of the Group.
	Not Applicable.

Item 9.	Notice of Dissolution of Group.
	Not Applicable.

Item 10.	Certifications.
	Not Applicable.

Schedule 13G

Page 5 of 5

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 14, 2003

Date

/s/ Allan Cochrane

Signature

Allan Cochrane / President

Name/Title

-----END PRIVACY-ENHANCED MESSAGE-----